Early Assay Development for Characterization & Qualification of Cardiac Cell Therapies

Time: 11:30 am
day: Day 2 Track 2 AM


  • The potential of cardiac cell therapy to treat heart failure
  • Features of developmental biology and physiology of cardiomyocytes which facilitate early analytical assay development
  • Pipeline of assays to characterize and qualify cardiomyocyte cell therapies